Diaceutics research predicts NSCLC US testing market to reach $3.6bn by 2025, but solution still needed to improve patient outcomes
Diaceutics PLC has published new research which predicts that the Non-Small Cell Lung Cancer (NSCLC) testing market will expand to $3.6 billion in the United St...